Silver Nanoparticles (AgNPs) Uptake by Caveolae-Dependent Endocytosis is Responsible for Their Selective Effect Towards Castration Resistant Prostate Cancer.
Male
Humans
Endocytosis
/ drug effects
Prostatic Neoplasms, Castration-Resistant
/ metabolism
Caveolae
/ metabolism
Silver
/ chemistry
Caveolin 1
/ metabolism
Metal Nanoparticles
/ chemistry
Cell Line, Tumor
MicroRNAs
/ metabolism
Cell Survival
/ drug effects
Caveolin 2
/ metabolism
Antineoplastic Agents
/ pharmacology
PC-3 Cells
caveolins
endocytosis
prostate cancer resistant to castration
silver nanoparticles
uptake mechanism
Journal
International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847
Informations de publication
Date de publication:
2024
2024
Historique:
received:
14
11
2023
accepted:
18
05
2024
medline:
11
9
2024
pubmed:
11
9
2024
entrez:
11
9
2024
Statut:
epublish
Résumé
Castration Resistant Prostate Cancer (CRPC) is characterized by poor prognosis and limited therapeutic options. AgNPs functionalized with glucose (G-AgNPs) were observed cytotoxic to CRPC cell lines (PC-3 and Du-145) and not LNCaP. This study aims to evaluate AgNPs and G-AgNPs' uptake mechanisms in these cells and understand their role in the selective effect against CRPC cells. Uptake of AgNPs and G-AgNPs was assessed through transmission electron microscopy (TEM). A microRNA (miRNAs) analysis approach was used to uncover the main molecular differences responsible for the endocytic mechanisms' regulation. Caveolin (Cav) 1 and 2 mRNA and protein levels were assessed in the three cell lines. Caveolae-dependent endocytosis was inhibited with genistein or siCav1 AgNPs and G-AgNPs were not uptaked by LNCaP. miRNA analysis revealed 37 upregulated and 90 downregulated miRNAs. Functional enrichment analysis of miRNAs' targets resulted in enrichment of terms related to endocytosis and caveolae. We observed that Cav1 and Cav2 are not expressed in LNCaP. Inhibiting caveolae-dependent endocytosis in Du-145 and PC-3 led to a significative reduction of cytotoxic capacity of AgNPs and G-AgNPs and induction of caveolae-dependent endocytosis in LNCaP lead to a significative increase as well as their uptake by cells. This study shows the potential of these AgNPs as a new therapeutic approach directed to CRPC patients, uncovers caveolae-dependent endocytosis as the uptake mechanism of these AgNPs and highlights deregulation of Cav1 and Cav2 expression as a key difference in hormone sensitive and resistant PCa cells which may be responsible for drug resistance.
Identifiants
pubmed: 39258003
doi: 10.2147/IJN.S447645
pii: 447645
pmc: PMC11384141
doi:
Substances chimiques
Silver
3M4G523W1G
Caveolin 1
0
MicroRNAs
0
CAV1 protein, human
0
Caveolin 2
0
CAV2 protein, human
0
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9091-9107Informations de copyright
© 2024 Morais et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.